Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News St Jude Medical completes acquisition of NeuroTherm

St Jude Medical completes acquisition of NeuroTherm

8th August 2014

St Jude Medical has announced the completion of its takeover of NeuroTherm, a move that will enhance its position in the chronic pain market.

NeuroTherm is a leading manufacturer of interventional pain management therapies, specialising in the treatment of spinal pain using radiofrequency ablation. This is a market that St Jude Medical did not participate in before now.

The $200 million (119.1 million pounds) deal sees the firm become the only medical device manufacturer with a chronic pain product portfolio that offers both radiofrequency ablation solutions for spinal pain and spinal cord stimulation.

This will expand the comprehensive range of radiofrequency products it offers worldwide for interventional pain management, including generators, electrodes and needles.

Michael Rousseau, St Jude Medical's chief operating officer, said: "This acquisition further demonstrates St Jude Medical's commitment to our chronic pain programme and our steadfast focus on improving patient outcomes."

Over the last year, the company has also launched two novel neuromodulation products, made a strategic investment in Spinal Modulation and initiated two clinical studies to evaluate alternatives for patients living with chronic pain.ADNFCR-8000103-ID-801740963-ADNFCR

We currently have 6 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.